# Clinical Cases: General Health and Preventive Medicine

## Case 1: Metabolic Syndrome Screening

### Patient Presentation
**Demographics:** 47-year-old male office manager

**Chief Complaint:** "I've been gaining weight and my doctor told me my blood pressure is creeping up."

**History of Present Illness:**
Mr. Rodriguez presents for a routine annual physical examination. Over the past three years, he reports a gradual weight gain of approximately 30 pounds, which he attributes to a sedentary desk job, frequent fast-food meals, and reduced physical activity since the COVID-19 pandemic. He notes that his pants size has increased from 34 to 40 inches.

He reports occasional headaches, increased thirst, and nocturia (waking twice nightly to urinate). He denies chest pain, dyspnea, or visual changes. He was told at a health fair six months ago that his blood pressure was "borderline high" but did not follow up. His wife has expressed concern about his snoring and witnessed apneic episodes during sleep.

He drinks two to three cans of regular soda daily and consumes alcohol socially (three to four beers per weekend). He does not smoke and has not engaged in structured exercise for over two years.

**Past Medical History:**
- No prior diagnoses
- No surgical history
- Childhood history unremarkable

**Medications:**
- Multivitamin daily
- Ibuprofen as needed for headaches

**Social History:**
- Office manager, sits 8-10 hours per day
- Married with two children
- Diet high in processed foods, refined carbohydrates, and sugary beverages
- No tobacco use; moderate alcohol use

**Family History:**
- Father: Type 2 diabetes mellitus, coronary artery disease (MI at age 58)
- Mother: Hypertension, hyperlipidemia
- Sister: Gestational diabetes

### Physical Examination
- **Vital Signs:** BP 142/92 mmHg (repeated 138/90 mmHg), HR 82 bpm, RR 16, Temp 98.4°F, SpO2 97%
- **General:** Obese male in no acute distress
- **HEENT:** Acanthosis nigricans noted on posterior neck; crowded oropharynx (Mallampati class IV)
- **Cardiovascular:** Regular rate and rhythm, no murmurs, no JVD
- **Respiratory:** Clear to auscultation bilaterally
- **Abdomen:** Central adiposity; waist circumference 42 inches; soft, non-tender, no hepatomegaly
- **Extremities:** No edema, pulses 2+ bilaterally
- **Skin:** Acanthosis nigricans in axillae bilaterally; skin tags on neck

### Workup and Results

**Laboratory Studies:**
| Test | Result | Reference Range |
|------|--------|-----------------|
| Fasting Glucose | 118 mg/dL | 70-99 mg/dL |
| HbA1c | 6.1% | < 5.7% |
| Total Cholesterol | 244 mg/dL | < 200 mg/dL |
| LDL Cholesterol | 162 mg/dL | < 100 mg/dL |
| HDL Cholesterol | 34 mg/dL | > 40 mg/dL |
| Triglycerides | 238 mg/dL | < 150 mg/dL |
| ALT | 52 U/L | 7-56 U/L |
| AST | 38 U/L | 10-40 U/L |
| Creatinine | 0.9 mg/dL | 0.7-1.3 mg/dL |
| Uric Acid | 7.8 mg/dL | 3.5-7.2 mg/dL |
| hsCRP | 3.8 mg/L | < 1.0 mg/L (low risk) |
| Fasting Insulin | 28 µIU/mL | 2-20 µIU/mL |

**Imaging/Additional Studies:**
- Liver ultrasound: Hepatic steatosis (fatty liver), no focal lesions
- ASCVD 10-year risk score: 12.4% (borderline-elevated)
- STOP-BANG score: 5 (high risk for obstructive sleep apnea)

### Clinical Image

![Diagnostic criteria diagram for metabolic syndrome showing the five components: central obesity, elevated triglycerides, low HDL, elevated blood pressure, and elevated fasting glucose](case_01_image.jpg)

*Diagram illustrating the five diagnostic criteria for metabolic syndrome according to the ATP III/IDF harmonized definition. Source: Educational illustration.*

### Diagnosis
**Metabolic Syndrome (ICD-10: E88.81)**

**Key Diagnostic Criteria (meets 4 of 5 — requires 3 of 5):**
- Waist circumference > 40 inches in males (patient: 42 inches)
- Triglycerides ≥ 150 mg/dL (patient: 238 mg/dL)
- HDL < 40 mg/dL in males (patient: 34 mg/dL)
- Blood pressure ≥ 130/85 mmHg (patient: 142/92 mmHg)
- Fasting glucose ≥ 100 mg/dL (patient: 118 mg/dL)

### Treatment Plan
1. **Lifestyle Modification (first-line):** Structured weight loss program targeting 7-10% body weight reduction over 6 months; Mediterranean-style diet with caloric restriction; eliminate sugary beverages
2. **Exercise Prescription:** 150 minutes/week moderate-intensity aerobic activity plus 2 days resistance training; start with 10-minute walking sessions and gradually increase
3. **Pharmacotherapy:** Initiate atorvastatin 20 mg daily given elevated ASCVD risk; consider metformin if lifestyle changes do not normalize glucose within 3 months
4. **Sleep Evaluation:** Refer for polysomnography given high STOP-BANG score
5. **Follow-up:** Recheck metabolic panel, lipids, and blood pressure in 3 months; dietitian referral; diabetes prevention program enrollment
6. **Monitoring:** Home blood pressure log; food and activity diary

### Key Learning Points
- Metabolic syndrome is diagnosed when 3 of 5 criteria are present and confers a 2-fold increased risk for cardiovascular disease and 5-fold increased risk for type 2 diabetes
- Acanthosis nigricans and elevated fasting insulin are clinical markers of insulin resistance, the pathophysiological driver of metabolic syndrome
- Lifestyle modification (diet, exercise, weight loss) remains the cornerstone of management and can resolve metabolic syndrome in up to 50% of patients
- Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome and should be screened for in affected patients
- Obstructive sleep apnea is strongly associated with metabolic syndrome and worsens insulin resistance, creating a bidirectional pathological relationship

---

## Case 2: Preventive Health Screening in a 50-Year-Old

### Patient Presentation
**Demographics:** 50-year-old female accountant

**Chief Complaint:** "I just turned 50 and want to make sure I'm up to date on all my health screenings."

**History of Present Illness:**
Ms. Chen presents for a comprehensive preventive health visit. She reports feeling generally well but acknowledges she has not had a thorough medical evaluation in over four years due to work demands. She notes occasional hot flashes over the past eight months, occurring three to four times daily, along with irregular menstrual periods (last menstrual period was six weeks ago, with cycles varying from 24 to 45 days over the past year).

She reports mild bilateral knee pain with prolonged standing and occasional heartburn after large meals. She denies any breast lumps, abnormal bleeding, weight loss, night sweats, or change in bowel habits. She has never had a colonoscopy. Her last Pap smear was approximately five years ago and was normal. She has never had a mammogram.

She works long hours during tax season (January through April), during which she reports high stress, poor sleep, and minimal exercise. Outside of tax season, she walks her dog for 20 minutes daily.

**Past Medical History:**
- Mild intermittent asthma (childhood, not active)
- Appendectomy at age 12
- No prior cancer screening beyond Pap smears

**Medications:**
- Calcium with vitamin D supplement daily
- Occasional omeprazole for heartburn

**Social History:**
- Non-smoker; never smoked
- Occasional glass of wine (1-2 per week)
- Lives with husband; two adult children
- Sedentary occupation; moderate stress levels

**Family History:**
- Mother: Breast cancer at age 62 (survived), osteoporosis
- Father: Colon polyps removed at age 55, hypertension
- Maternal aunt: Ovarian cancer at age 68

### Physical Examination
- **Vital Signs:** BP 126/78 mmHg, HR 72 bpm, RR 14, Temp 98.6°F, BMI 26.2 kg/m²
- **General:** Well-appearing female in no acute distress
- **HEENT:** Normocephalic, no thyromegaly, no lymphadenopathy
- **Cardiovascular:** Regular rate and rhythm, no murmurs
- **Respiratory:** Clear bilaterally
- **Breast:** No masses, no nipple discharge, no skin changes, no axillary lymphadenopathy
- **Abdomen:** Soft, non-tender, well-healed RLQ scar, no masses
- **Musculoskeletal:** Mild crepitus bilateral knees; full ROM
- **Neurological:** Grossly intact; PHQ-2 score 1 (negative screen)

### Workup and Results

**Laboratory Studies:**
| Test | Result | Reference Range |
|------|--------|-----------------|
| CBC | WNL | — |
| TSH | 3.2 mIU/L | 0.4-4.0 mIU/L |
| FSH | 42 mIU/mL | Postmenopausal > 30 |
| Fasting Glucose | 94 mg/dL | 70-99 mg/dL |
| HbA1c | 5.4% | < 5.7% |
| Total Cholesterol | 218 mg/dL | < 200 mg/dL |
| LDL Cholesterol | 138 mg/dL | < 100 mg/dL |
| HDL Cholesterol | 58 mg/dL | > 50 mg/dL (female) |
| Triglycerides | 112 mg/dL | < 150 mg/dL |
| Vitamin D, 25-OH | 24 ng/mL | 30-100 ng/mL |
| Calcium | 9.4 mg/dL | 8.5-10.5 mg/dL |

**Imaging/Additional Studies:**
- Mammogram: BI-RADS 1 (negative); dense breast tissue noted (category C)
- DEXA scan: Lumbar spine T-score -1.2 (osteopenia); femoral neck T-score -0.9 (normal)
- ASCVD 10-year risk: 4.2% (low)

### Clinical Image

![Age-appropriate preventive screening timeline for a 50-year-old female showing recommended cancer screenings, immunizations, and metabolic assessments](case_02_image.jpg)

*Preventive health screening timeline for women at age 50, including USPSTF-recommended cancer screenings, immunizations, and metabolic assessments. Source: Educational illustration.*

### Diagnosis
**Perimenopause with Preventive Health Screening Needs (ICD-10: Z00.00, N95.1)**

**Key Diagnostic Criteria:**
- Elevated FSH with irregular menstrual cycles consistent with perimenopause
- Vitamin D insufficiency (24 ng/mL)
- Mild osteopenia on DEXA
- Mildly elevated LDL cholesterol
- Family history placing her at increased risk for breast and colorectal cancer

### Treatment Plan
1. **Cancer Screening Initiation:** Schedule screening colonoscopy (average risk begins at 45; family history of polyps warrants priority); continue annual mammograms given dense breast tissue and family history — discuss supplemental MRI screening based on lifetime risk calculation
2. **Cervical Cancer Screening:** Pap smear with HPV co-testing today; if both negative, repeat in 5 years per USPSTF guidelines
3. **Vitamin D Repletion:** Increase vitamin D3 to 2000 IU daily; recheck level in 3 months
4. **Osteopenia Management:** Weight-bearing exercise prescription; ensure adequate calcium (1200 mg/day total) and vitamin D; repeat DEXA in 2 years
5. **Cardiovascular Risk:** Lifestyle modification for LDL reduction (dietary changes); reassess in 6 months for statin consideration if LDL remains elevated
6. **Perimenopause:** Counsel on vasomotor symptom management options; discuss hormone replacement therapy risks and benefits given family history
7. **Immunizations:** Administer flu vaccine; verify Tdap within 10 years; discuss shingles vaccine at age 50 (Shingrix, 2-dose series)
8. **Lung Cancer Screening:** Not indicated (never-smoker)

### Key Learning Points
- The USPSTF recommends colorectal cancer screening beginning at age 45 for average-risk adults; family history of adenomatous polyps in a first-degree relative may warrant earlier initiation depending on age of diagnosis
- Women with dense breast tissue (ACR categories C or D) have both increased breast cancer risk and decreased mammographic sensitivity, warranting discussion of supplemental screening modalities
- Vitamin D insufficiency is common and contributes to osteopenia; repletion and weight-bearing exercise are first-line interventions for bone health in perimenopausal women
- Perimenopause is a clinical diagnosis based on menstrual irregularity and vasomotor symptoms, supported by elevated FSH; it is not defined by a single lab value
- Preventive visits at milestone ages represent critical opportunities to initiate age-appropriate screenings and update immunizations — a structured checklist approach prevents gaps in care

---

## Case 3: Health Literacy and Medication Adherence

### Patient Presentation
**Demographics:** 63-year-old male retired construction worker

**Chief Complaint:** "My sugar has been running high and I don't understand why — I've been taking my pills."

**History of Present Illness:**
Mr. Williams was diagnosed with type 2 diabetes mellitus eight years ago and hypertension twelve years ago. He presents to the clinic after his home glucometer readings have consistently been between 250 and 350 mg/dL over the past three weeks. He states he has been "taking his pills" but upon detailed questioning, significant adherence issues emerge.

When asked to describe his medication regimen, Mr. Williams states he takes "the white pill in the morning and the other one at night." He is unable to name any of his medications, state their doses, or articulate their purposes. He recently received a 90-day mail-order refill and reveals that he has been taking metformin 500 mg once daily instead of the prescribed 1000 mg twice daily because "the bottle said 500 so I take one." He discontinued his glipizide two months ago because "it was making me dizzy" but did not inform his physician. He takes lisinopril intermittently, only when he "feels his pressure is up."

He completed education through 10th grade and reports difficulty reading medication labels and patient education materials. He does not use a smartphone and relies on his daughter to schedule appointments.

**Past Medical History:**
- Type 2 diabetes mellitus (8 years)
- Hypertension (12 years)
- Hyperlipidemia
- Diabetic peripheral neuropathy
- Osteoarthritis of bilateral knees

**Medications (prescribed vs. actual):**
- Metformin 1000 mg BID (taking 500 mg once daily)
- Glipizide 10 mg BID (discontinued 2 months ago)
- Lisinopril 20 mg daily (taking intermittently)
- Atorvastatin 40 mg daily (taking consistently)
- Gabapentin 300 mg TID (taking once daily at bedtime only)

**Social History:**
- Retired construction worker; limited pension income
- 10th grade education; limited health literacy
- Lives alone; daughter visits weekly
- Former smoker (30 pack-years, quit 5 years ago)
- No alcohol use

**Family History:**
- Mother: Diabetes, stroke
- Father: Unknown (estranged)
- Brother: Diabetes, below-knee amputation

### Physical Examination
- **Vital Signs:** BP 158/94 mmHg, HR 88 bpm, RR 18, Temp 98.2°F, BMI 32.1 kg/m², fingerstick glucose 312 mg/dL
- **General:** Obese male, appears older than stated age
- **HEENT:** Cotton-wool spots on fundoscopic exam bilaterally; no rubeosis iridis
- **Cardiovascular:** Regular rate and rhythm; S4 gallop present
- **Respiratory:** Clear to auscultation
- **Abdomen:** Obese, non-tender
- **Extremities:** Decreased sensation to monofilament testing bilateral feet (4/10 sites); dry skin with fissuring bilateral heels; pulses diminished dorsalis pedis bilaterally
- **Neurological:** Decreased vibratory sensation bilateral great toes; absent ankle reflexes

### Workup and Results

**Laboratory Studies:**
| Test | Result | Reference Range |
|------|--------|-----------------|
| HbA1c | 10.4% | < 7.0% (goal) |
| Fasting Glucose | 298 mg/dL | 70-99 mg/dL |
| Creatinine | 1.6 mg/dL | 0.7-1.3 mg/dL |
| eGFR | 48 mL/min/1.73m² | > 60 mL/min/1.73m² |
| BUN | 32 mg/dL | 7-20 mg/dL |
| Urine Albumin/Creatinine Ratio | 186 mg/g | < 30 mg/g |
| Potassium | 5.1 mEq/L | 3.5-5.0 mEq/L |
| Total Cholesterol | 198 mg/dL | < 200 mg/dL |
| LDL Cholesterol | 112 mg/dL | < 100 mg/dL |
| HbA1c (6 months ago) | 8.2% | < 7.0% |

**Imaging/Additional Studies:**
- Diabetic retinal screening: Mild non-proliferative diabetic retinopathy bilateral
- Monofilament exam: Loss of protective sensation bilateral feet
- Medication Possession Ratio (pharmacy data): 42% for metformin, 0% for glipizide, 58% for lisinopril

### Clinical Image

![Infographic showing the relationship between health literacy, medication adherence, and clinical outcomes in chronic disease management](case_03_image.jpg)

*Diagram illustrating how low health literacy contributes to medication non-adherence and poor clinical outcomes, with intervention strategies at each level. Source: Educational illustration.*

### Diagnosis
**Uncontrolled Type 2 Diabetes Mellitus due to Medication Non-Adherence Secondary to Limited Health Literacy (ICD-10: E11.65, Z55.0)**

**Key Diagnostic Criteria:**
- HbA1c rising from 8.2% to 10.4% over 6 months
- Medication Possession Ratio well below the 80% adherence threshold
- Unable to name medications, state doses, or describe indications
- Evidence of end-organ damage: nephropathy (eGFR 48, albuminuria), retinopathy, neuropathy
- Validated low health literacy on REALM assessment (4th grade reading level)

### Treatment Plan
1. **Health Literacy Assessment:** Administer REALM (Rapid Estimate of Adult Literacy in Medicine) — result: 4th grade reading level; all future communication to use teach-back method and plain language
2. **Medication Simplification:** Transition to once-daily combination medications where possible; consider empagliflozin (renal and cardiovascular benefit given CKD stage 3b and albuminuria) replacing glipizide; continue metformin at reduced dose (500 mg BID given eGFR)
3. **Adherence Tools:** Pill organizer with color-coded compartments; pictographic medication schedule (pictures instead of text); enlist daughter as health care proxy and medication manager
4. **Diabetes Education:** Referral to certified diabetes care and education specialist (CDCES) for low-literacy tailored education; focus on survival skills first (hypoglycemia recognition, when to seek emergency care)
5. **Nephrology Referral:** eGFR < 50 with significant albuminuria warrants nephrology co-management
6. **Ophthalmology Follow-up:** Repeat dilated eye exam in 6 months given NPDR
7. **Foot Care:** Podiatry referral; therapeutic footwear prescription; daily foot inspection education using teach-back
8. **Follow-up:** Return in 2 weeks for medication reconciliation; monthly visits until HbA1c trending below 8%

### Key Learning Points
- Approximately 36% of U.S. adults have limited health literacy, which is independently associated with a 1.5 to 3-fold increase in adverse health outcomes and hospitalizations
- The teach-back method ("Tell me in your own words how you take this medication") is the single most effective communication technique for confirming patient understanding
- Medication Possession Ratio (MPR) calculated from pharmacy refill data is an objective measure of adherence; an MPR below 80% is associated with significantly worse outcomes in diabetes and hypertension
- Medication regimen simplification (reducing pill burden, using combination products, once-daily dosing) improves adherence by 20-30% in patients with low health literacy
- End-organ damage in diabetes (retinopathy, nephropathy, neuropathy) often progresses silently; patients with adherence barriers require proactive screening protocols rather than symptom-based evaluation